$レノバロ (RENB.US)$レノバーロキューブが、オックスフォードナノポアシーケンシングを使用した非侵襲的ながん診断に関する新しい見解を発表します
RenovaroCube (NASDAQ: RENB), a leader in AI-driven cancer diagnostics, presented groundbreaking research at the Molecular Analysis for Precision Oncology Congress on October 16, 2024. The study explores the use of Oxford Nanopore sequencing on circulating cell-free DNA (cfDNA) from blood plasma to detect copy number alterations (CNAs) in lung cancer patients.
Key findi...
